BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 694476)

  • 1. Increased plasma DR-70 (fibrinogen-fibrin degradation products) concentrations as a diagnostic biomarker in dogs with neoplasms.
    Ke CH; Sio KM; Wu CH; Xia YY; Lee JJ; Hu CH; Liu CC; Lu CL; Cheng CL; Lin KH; Tomiyasu H; Wang YS; Lin CS
    J Vet Intern Med; 2023; 37(6):2391-2401. PubMed ID: 37837297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced fibrinolysis detection in a natural occurring canine model with intracavitary effusions: Comparison and degree of agreement between thromboelastometry and FDPs, D-dimer and fibrinogen concentrations.
    Zoia A; Drigo M; Piek CJ; Calcini H; Caldin M; Simioni P
    PLoS One; 2019; 14(11):e0225089. PubMed ID: 31725761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostatic findings of pleural fluid in dogs and the association between pleural effusions and primary hyperfibrino(geno)lysis: A cohort study of 99 dogs.
    Zoia A; Drigo M; Piek CJ; Simioni P; Caldin M
    PLoS One; 2018; 13(2):e0192371. PubMed ID: 29462172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Mombelli G; Monotti R; Haeberli A; Straub PW
    Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity.
    Hatton MW; Southward SM; Legault KJ; Ross BL; Clarke BJ; Bajzar L; Blajchman MA; Singh G; Richardson M
    J Lab Clin Med; 2004 Apr; 143(4):241-54. PubMed ID: 15085083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships among tumor burden, tumor size, and the changing concentrations of fibrin degradation products and fibrinolytic factors in the pleural effusions of rabbits with VX2 lung tumors.
    Hatton MW; Southward SM; Ross BL; Clarke BJ; Singh G; Richardson M
    J Lab Clin Med; 2006 Jan; 147(1):27-35. PubMed ID: 16443002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
    Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
    Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological significance of fibrinopeptide A elevation in the blood].
    Mombelli G; Hofmann V; Straub PW
    Schweiz Med Wochenschr; 1977 Dec; 107(48):1779-81. PubMed ID: 579262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen, fibrin(ogen) degradation products and fibrinopeptide A in pleural effusions. High turnover of fibrinogen in pleurisy.
    Widström O; Kockum C; Nilsson BS
    Scand J Respir Dis; 1978 Aug; 59(4):210-5. PubMed ID: 694476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of proteases, plasminogen activators, fibrin fibrinogen degradation products and fibrinopeptides in the growth and development of neoplasms and neoplasm metastases].
    Farbiszewski R
    Postepy Hig Med Dosw; 1984; 38(2):133-55. PubMed ID: 6393101
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel aspects of fibrin(ogen) fragments during inflammation.
    Jennewein C; Tran N; Paulus P; Ellinghaus P; Eble JA; Zacharowski K
    Mol Med; 2011; 17(5-6):568-73. PubMed ID: 21210072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen, fibrin and the arterial wall.
    Smith EB
    Eur Heart J; 1995 Mar; 16 Suppl A():11-4; discussion 14-5. PubMed ID: 7796823
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.